REGN(REGN)
REGN
Q3 2026 EPS Estimate
$10.85
Jul 30, 2026 · Reports before open
Revenue Estimate
$3.82B
FY2026E EPS$46.46
FY2027E EPS$54.15
Analyst Sentiment
Wall St. Consensus
Buy23 analysts·High coverage
68
Score
17 Buy (74%)6 Hold (26%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
1774%
Hold
626%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$641.00
+1.3%
Consensus
$857.50
+35.5%
Bull
$995.00
+57.2%
12-Month Target Range23 analysts
$641.00$857.50$995.00
Current $632.90Consensus
Current Price
$632.90
Upside to Consensus
$224.60
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+10.61%
EPS+16.56%
FY2028
Rev+7.44%
EPS+12.41%
FY2029
Rev+10.80%
EPS+18.40%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $15.92B | $17.61B | $18.92B | $20.97B | $21.46B |
| Low | $15.24B | $16.10B | $18.91B | $19.47B | $19.93B |
| High | $16.68B | $19.21B | $18.93B | $22.59B | $23.13B |
| EBITDA Avg | $6.92B | $7.65B | $8.22B | $9.11B | $9.32B |
| Low | $6.62B | $6.99B | $8.21B | $8.46B | $8.65B |
| High | $7.25B | $8.34B | $8.22B | $9.81B | $10.04B |
| EBIT Avg | $6.44B | $7.12B | $7.65B | $8.48B | $8.68B |
| Low | $6.16B | $6.51B | $7.65B | $7.87B | $8.06B |
| High | $6.75B | $7.77B | $7.65B | $9.14B | $9.35B |
| Net Income Avg | $4.97B | $5.13B | $5.79B | $7.83B | $7.76B |
| Low | $4.51B | $3.27B | $5.40B | $7.10B | $7.04B |
| High | $5.43B | $7.16B | $8.05B | $8.62B | $8.54B |
| EPS Avg | $46.46 | $54.15 | $60.88 | $72.07 | $71.47 |
| Low | $41.54 | $30.14 | $49.75 | $65.38 | $64.83 |
| High | $49.99 | $65.95 | $74.09 | $79.35 | $78.68 |
| Analysts (Rev / EPS) | 20 / 16 | 20 / 9 | 22 / 8 | 15 / 6 | 11 / 6 |
Quarterly
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $3.82B | $4.20B | $4.35B | $3.93B | $4.29B | $4.52B | $5.05B |
| Low | $3.65B | $3.82B | $3.95B | $3.57B | $3.90B | $4.11B | $4.58B |
| High | $4.18B | $4.52B | $4.79B | $4.34B | $4.73B | $4.99B | $5.57B |
| EBITDA Avg | $1.66B | $1.82B | $1.89B | $1.71B | $1.86B | $1.96B | $2.19B |
| Low | $1.59B | $1.66B | $1.71B | $1.55B | $1.69B | $1.78B | $1.99B |
| High | $1.82B | $1.96B | $2.08B | $1.88B | $2.06B | $2.17B | $2.42B |
| EBIT Avg | $1.54B | $1.70B | $1.76B | $1.59B | $1.74B | $1.83B | $2.04B |
| Low | $1.48B | $1.55B | $1.60B | $1.44B | $1.58B | $1.66B | $1.85B |
| High | $1.69B | $1.83B | $1.94B | $1.75B | $1.91B | $2.02B | $2.25B |
| Net Income Avg | $1.17B | $1.41B | $1.41B | $1.24B | $1.43B | $1.55B | $1.86B |
| Low | $911M | $1.05B | $1.24B | $1.09B | $1.26B | $1.37B | $1.64B |
| High | $1.46B | $1.62B | $1.59B | $1.40B | $1.62B | $1.76B | $2.11B |
| EPS Avg | $10.85 | $13.08 | $13.06 | $11.50 | $13.26 | $14.41 | $17.26 |
| Low | $8.46 | $9.75 | $11.50 | $10.12 | $11.67 | $12.68 | $15.19 |
| High | $13.55 | $15.07 | $14.81 | $13.04 | $15.03 | $16.33 | $19.56 |
| Analysts (Rev / EPS) | 13 / 15 | 13 / 15 | 6 / 10 | 6 / 6 | 6 / 6 | 6 / 6 | 6 / 6 |